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Synopsis
DNA ligases are enzymes that seal breaks in the backbones of DNA, leading to them being essential for the survival
of all organisms. DNA ligases have been studied from many different types of cells and organisms and shown to
have diverse sizes and sequences, with well conserved specific sequences that are required for enzymatic activity.
A significant number of DNA ligases have been isolated or prepared in recombinant forms and, here, we review their
biochemical and structural characterization. All DNA ligases contain an essential lysine that transfers an adenylate
group from a co-factor to the 5′-phosphate of the DNA end that will ultimately be joined to the 3′-hydroxyl of the
neighbouring DNA strand. The essential DNA ligases in bacteria use β -nicotinamide adenine dinucleotide (β -NAD+ )
as their co-factor whereas those that are essential in other cells use adenosine-5′-triphosphate (ATP) as their co-
factor. This observation suggests that the essential bacterial enzyme could be targeted by novel antibiotics and
the complex molecular structure of β -NAD+ affords multiple opportunities for chemical modification. Several recent
studies have synthesized novel derivatives and their biological activity against a range of DNA ligases has been
evaluated as inhibitors for drug discovery and/or non-natural substrates for biochemical applications. Here, we
review the recent advances that herald new opportunities to alter the biochemical activities of these important
enzymes. The recent development of modified derivatives of nucleotides highlights that the continued combination of
structural, biochemical and biophysical techniques will be useful in targeting these essential cellular enzymes.
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DNA LIGASES
The family of enzymes classified as nucleotidyl transferases play
important roles in the metabolism of nucleic acids due to their
ability to transfer phosphorus-containing groups between bio-
molecules. An important member of this family are the DNA
ligases, which are essential to all living cells due to their roles in
DNA replication, repair and recombination [1–7]. DNA ligases
participate in a range of cellular reactions, with their role particu-
larly well characterized for the joining of Okazaki fragments that
are synthesized on the lagging (discontinuous) strand during rep-
lication. The biochemical activity of DNA ligases results in the
sealing of breaks between 5′-phosphate and 3′-hydroxyl termini
within a strand of DNA. DNA ligases have been differentiated as
being adenosine-5′-triphosphate (ATP)-dependent (EC 6.5.1.1)
or NAD+ -dependent (EC 6.5.1.2) depending on the co-factor (or
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co-substrate) that is used during their reaction [2,3,8]. Typically,
more than one type of DNA ligase is found in each organism
[1–3,6,9,10]. Here, we review current biochemical and structural
knowledge of these enzymes from bacteria and archaea. In addi-
tion, we go on to highlight modifications of co-factors that alter
the biochemical activities of these important enzymes, with a
particular focus on altered forms of β-nicotinamide adenine di-
nucleotide (β-NAD+ ). Recent developments in identifying such
compounds as selective inhibitors of a range of NAD+ -dependent
enzymes is encouraging for their development as potential drug
candidates [8,11,12].
DNA ligases from several sources were first isolated by several
research groups during the 1960s and their reaction mechanisms
were soon elucidated [13]. It was quickly realized that DNA
ligases are extremely useful tools in molecular biological ma-
nipulations of DNA, which has led to their widespread usage
in biotechnological applications [7,14,15]. In the case of both
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Figure 1 Conserved domains within the ATP-dependent DNA ligases from bacteria and archaea
Schematic diagram indicating the position of conserved domains within the ATP-dependent DNA ligases identified in
bacterial and archaeal genomes. Only protein domains matching to Pfam families [16] are referred to and polypeptide
regions with no match are not depicted. Domains are not shown to scale. Sizes refer to numbers of amino acids in the
largest protein within each domain architecture according to the Pfam database. Note that two related forms of LigD2
are observed within sequence databases. Details are adapted from [10]: Williamson, A., Hjerde, E. and Kahlke, T. (2016)
Analysis of the distribution and evolution of the ATP-dependent DNA ligases of bacteria delineates a distinct phylogenetic
group ‘Lig E’. Mol. Microbiol. 99, 274–290.
ATP-dependent DNA ligases (ADLs) and NAD+ -dependent
DNA ligases (NDLs), the joining of DNA breaks occurs via
a ping-pong mechanism and the biochemical details are well-
characterized for many DNA ligases [1–7]. (For NDLs, the reac-
tion mechanism is discussed further below in reference to Figure
5.) Briefly, in the first interaction between the enzyme and co-
factor, β-NAD+ (or ATP) binds to the active site of the enzyme;
there, a nucleophilic lysine residue attacks the phosphate of the
adenosine in the co-factor with subsequent release of the leaving
group, β-nicotinamide mononucleotide (β-NMN) for NDLs (or
PPi for ADLs). After the positioning of the DNA nick in the
proximity of the adenylated-ligase intermediate, the nucleophilic
phosphate in the 5′ position of the DNA attacks the phosphor-
amidate bond to form an adenylated-DNA intermediate. Finally,
the nucleophilic hydroxyl group in the 3′ position of the DNA
attacks the new pyrophosphate bond with formation of a phos-
phodiester bond between the 5′ and 3′ positions of the DNA and
release of AMP. As will be discussed within this review, structural
studies using a range of enzymes have demonstrated that large-
scale conformational movements take place for ligation reactions
performed by NDLs and ADLs.
Although they all perform the same biochemical reaction,
DNA ligases have been identified with a range of structures that
incorporate a core ‘adenylation domain’ linked to other well-
defined domains (Figures 1 and 2) [3,5–7]. The adenylation do-
mains of ADLs and NDLs perform a similar enzymatic reaction,
but they have key differences within their structures, as indicated
by their presence as distinct domains within the Pfam database
of proteins [16]. To highlight the key similarities and differences
across ADLs and NDLs, we will briefly review the structural
knowledge that informs biochemical function for the two classes
of DNA ligases from bacteria and archaea. Notably, the evolu-
tionary relationship between archaea and eukaryotes has recently
been re-evaluated [17–19]. It is now clear that many genes have
been transferred ‘horizontally’ from and into archaeal genomes,
and this is almost certainly true for genes that encode DNA lig-
ases. Thus, an evolutionary understanding of these genes may not
be straightforward and it may be more useful for certain types of
organisms than others. Nonetheless, detailed phylogenetic studies
of essential cellular genes such as DNA ligases may offer useful
information in relation to the evolution of eukaryotic cells, but
this potential will not be considered in detail within this review.
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Figure 2 Conserved domains within the NAD+ -dependent DNA ligases from bacteria
(A) Schematic diagram indicating the approximate size and position of domains conserved within the NAD+ -dependent
DNA ligase (LigA) identified in E. coli. Only protein domains matching to Pfam families [16] are included and polypeptide
regions with no match are not depicted. Domains are not shown to scale. Note that these Pfam domains are present
in the majority of bacterial NAD+ -dependent DNA ligases, though some contain additional Pfam domains that are not
present in E. coli LigA. (B) High-resolution structure of E. coli LigA in complex with nicked adenylated DNA from PDB 2OWO
[55], visualized by UCSF Chimera. The various domains are indicated by different colours and relate to Pfam domains as
follows: subdomain 1a (light blue) and subdomain 1b (green/cyan) is equivalent to PF01653; OB-fold/domain 2 (yellow) is
equivalent to PF03120; subdomain 3a (red) is equivalent to PF03119; subdomain 3b (orange) is equivalent to PF14520;
the adenylated-DNA molecule is shown in grey. Note that the BRCA1 C-terminus (BRCT) domain (equivalent to PF00533)
is not resolved in the crystallographic structure.
STRUCTURE AND FUNCTIONS OF
ATP-DEPENDENT DNA LIGASES
ADLs occur in the genomes of all domains of life [1–3,6,9,10].
Viruses contain a diverse range of ADLs, whereas eukaryotes
contain three main types of ADLs, although mitochondrial and
nuclear localization signals direct some versions of the proteins
to specific organelles [20]. Biochemical and structural details of
DNA ligases from different organisms have been reviewed [1,3–
7,9,20]. In this review we focus attention on DNA ligases from
bacteria and, to a limited extent, archaea.
ADLs encoded within the genomes of archaea are relatively
homologous in size and sequence, whereas those from bacteria
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have a wider diversity of total size and domain arrangements
[2,10,14]. In the majority of archaea studied to date, the only
functional genes for DNA ligases encode proteins that are of
the ATP-dependent type, so the proteins they encode participate
in all aspects of DNA metabolism. By contrast, where ADLs
are found in bacteria, it is always in addition to, rather than
instead of, NDLs and it is the NAD+ -dependent versions that
are essential [21], which we discuss below in more detail. The
physiological requirements for so many different bacterial ADLs
are not fully clear, though they appear to be not essential and are
sometimes only expressed under particular growth conditions
[2,22–26]. Furthermore, significant numbers of bacteria do not
possess any genes for ADLs [2]. High-resolution structures exist
for several ADLs from archaea [27–33] and bacteria [34,35].
In addition to their core adenylation domain, many ADLs
include extra domains and motifs that enhance DNA binding,
bring additional enzymatic activities or link them to macro-
molecular complexes that are important in specific aspects of
DNA metabolism. With this knowledge it is not surprising that
ADLs undergo large-scale conformational movements during
the DNA ligation reactions. To assist comparison of the different
types of ADLs (Figure 1), we follow the approach of Williamson
et al. [10] and use the terminology from the Pfam database of
proteins [16]. Distinct domains have a specific Pfam identifier,
and those identified in ADLs are often found in other proteins
involved in DNA metabolism. Note that PF01896 corresponds
to DNA primase, which synthesizes short fragments of nucleic
acid, usually RNA; PF01896 is not always recognized within
DNA ligase sequences in the Pfam database, but these regions
are usually annotated region as the Pol domain of LigD, which
corresponds to this domain [10]. From this type of analysis of
protein families it becomes clear that ADLs have significant
diversity in their domains and in the way these are organized
within a single polypeptide (Figure 1).
Where bacteria do encode ADLs within their genomes, the
number of genes varies widely – though it is relatively consistent
within each bacterial genus [2,10]. Three classes of these en-
zymes (LigB, LigC and LigD) appear to have descended from a
common ancestor within bacteria. It is important to note that the
various domains (and their corresponding biochemical activit-
ies) are arranged in different organizations within the LigD class
of enzymes (Figure 1), which have been given different names
[10]. This same recent comparison of the domain structure of dif-
ferent types of ADLs and their distribution among bacteria also
delineated an additional group, termed LigE (Figure 1). These en-
zymes possess several unique features, suggesting that the genes
encoding LigE-type proteins were horizontally transferred into
bacteria in a separate event from other bacterial ADLs.
Functional characterization of the ADLs has delineated that
the four classes of genes contain different organization of the
structural domains found within the Pfam database [10]. The
arrangement of the domains varies between species, but there are
clear groupings of functional domains, as illustrated in Figure 1.
The different domains are likely to promote interactions between
the DNA ligase and other proteins, ensuring that the DNA-sealing
polypeptide is targeted to specific processes or types of DNA
ends. A number of observations suggest that ADLs assist the
efficiency of DNA repair, with the best evidence being available
for the non-homologous end-joining (NHEJ) system that repairs
double-stranded breaks in DNA. The LigD proteins are required
for efficient NHEJ that involve interactions with Ku proteins
that also participate in NHEJ, but the LigC proteins also act as
a back-up system [22–26,34,36–40]. Furthermore, the multiple
enzymatic modules that are present within the large LigD proteins
include a DNA-primase/polymerase domain and in some cases a
phosphoesterase domain, and these activities are able to alter the
structure and sequence of the ends before repairing them [41–45].
Bacterial ADLs have been demonstrated to have DNA end-
joining activities by a variety of methods and assays, but the
non-essential nature of these genes suggests that they are not
functional as replicative DNA ligases. This is clearly different
from the situation in the majority of archaea, where ADLs must
participate in replication in each organism. The widespread pres-
ence of genes for ADLs in bacteria suggests that their protein
products have important activities in DNA metabolism with their
host cells. It seems likely that the various classes of ADLs have
different physiological functions and, indeed, the function of a
specific class may vary in different organisms. A number of pos-
sible functions have been suggested for these enzymes [10,22–
26], but further research is required to clarify the usefulness of
the various types of ADLs in different organisms.
STRUCTURE AND FUNCTIONS OF
NAD + -DEPENDENT DNA LIGASES
In contrast with the widespread presence of functional ADLs
across cell types, the majority of functional NDLs have only
been identified within the genomes of all bacteria and some vir-
uses. In bacteria the genes are essential, presumably due to the
requirement of their protein product for efficient DNA replica-
tion [21]. As discussed in detail below, the essential nature of
the NDLs for bacterial viability make them a possible target for
novel anti-bacterial drugs. Novel chemicals that are developed for
such approaches also provide useful compounds for biochemical
characterization of DNA ligases.
Some archaeal organisms encode NDLs, including Methano-
methylophilus alvus [46] and, potentially, the recently discovered
lokiarchaeota [19]. In contrast with the majority of archaea stud-
ied to date, genetic- and microbiology-based studies have con-
firmed the cellular requirement of an NDL homologue in the
halophile Haloferax volcanii [47,48]. Phylogenetic analysis sug-
gests the genes encoding these enzymes were most probably
acquired as a result of horizontal gene transfer from bacteria
[47,49]. Biochemical and structural characterization of NDLs
encoded by archaeal genomes will illuminate the evolutionary
history of these enzymes and help with the development of drugs
that are specifically targeted against bacterial NDLs.
NDLs from different bacteria have been structurally character-
ized to better understand their activities and reaction mechanism,
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Table 1 Essential amino acids and their roles in the NTase domains of β-NAD+ -dependent DNA ligases from E. coli [59,60] and M.
tuberculosis [54,61]
‘Roles’ refer to the biochemical mechanism of DNA ligases, as shown in Figure 5.
Residue Interaction Role
E. coli K115 Part of KXDG conserved motif; nucleophilic attack
to adenosine phosphate of β -NAD+
Formation of adenylated-ligase intermediate
M. tuberculosis K123
E. coli D117 Part of KXDG conserved motif Stabilization of active site
M. tuberculosis D125
E. coli G118 Part of KXDG conserved motif Stabilization of active site
M. tuberculosis G126
E. coli E173 Coordination of O-2′ of the adenosine ribose in
β -NAD+ and AMP
Involved in formation of adenylated-ligase
intermediate and sealing of nick
M. tuberculosis E184
E. coli K290 H-bonding with N-1 on adenine ring Stabilization of adenine conformation
M. tuberculosis K300
E. coli Y225 Stacking interaction with adenine ring Stabilization of adenine conformation
M. tuberculosis H236
E. coli E113 H-bonding with N-6 on adenine ring Stabilization of adenine conformation
M. tuberculosis E121
and to aid the development of possible inhibitors against these
enzymes [3–5,7,8]. High levels of homology have been found
between sequences of bacterial NDLs, showing highly conserved
motifs and the same modular architecture. The sequence similar-
ity with ADLs is quite poor, as expected because of the different
co-factor; however, NDLs and ADLs share a similar biochemical
reaction mechanism, as highlighted above [2,5,7,8].
The first crystallographic structure of an NDL was a partial
structure that included the adenylation domain from the enzyme
from Bacillus stearothermophilus [50]. Shortly after, a more com-
plete and biochemically informative structure was obtained for
the NDL from Thermus filiformis [51]. Other high-resolution
structures have been resolved for the homologous enzymes from
Enterococcus faecalis [52,53], Mycobacterium tuberculosis [54],
Escherichia coli [55,56], Haemophilus influenzae [57], Strepto-
coccus pneumoniae [56] and Staphylococcus aureus [58]. Many
of the structures contain only fragments of the enzyme, but some
have ligands incorporated. Comparison of the different structures
reveals that the NDLs have a modular architecture consisting of
four main domains (Figures 2A and 2B), which incorporate a
number of domains from the Pfam database [16]. This rather com-
plex conformation leads to several important features for the re-
action mechanism of NDLs. Domain 1 (incorporating PF01653)
is formed by two subdomains; subdomain 1a, at the N-terminus,
binds the β-NMN moiety of β-NAD+ , whereas subdomain 1b
is the adenylation domain, or the nucleotidyltransferase domain
(NTase), since it binds the AMP moiety of β-NAD+ . Domain 2
is the oligonucleotide binding site (OB), analogous to PF03120.
Domain 3 consists of subdomain 3a, a Cys4-type zinc finger
(equivalent to PF03119), and subdomain 3b, containing a helix–
hairpin–helix motif (HhH) (equivalent to PF14520). Domain 4,
at the C-terminus, is a BRCT domain (breast cancer carboxy-
terminal), analogous to PF00533. Note that, typically, the BRCT
is not resolved in crystallographic structures of NDLs (e.g. as
shown in Figure 2B).
The catalytic core of NDLs consists of subdomain 1b and
domain 2 (OB-fold), flanked by N- and C-terminal domains ar-
ranged in a C-shape that clamps the double-stranded DNA [2–
5,7,8]. Subdomain 1a has been shown to interact with the β-NMN
moiety of β-NAD+ and, indeed, it is not present in ADLs [59]. Its
presence is fundamental to initiate the ligation reaction of NDLs,
but is not essential in the case of the interaction of preadenylated-
enzyme with DNA; this means that subdomain 1a is required for
the β-NAD+ binding and the adenylation step. From the crys-
tallographic studies, it was possible to identify an ‘open’ enzyme
conformation, in which β-NAD+ was bound to the solvent ex-
posed NTase domain. Therefore, the closure of subdomain 1a to
bury β-NAD+ puts β-NMN in an apical position as a leaving
group during the nucleophilic attack of the lysine residue on the
adenosine phosphate; the subdomain 1a has to swivel by almost
180◦ to switch from the ‘open’ to the ‘closed’ conformation [52].
Subdomain 1b contains the adenylation domain of NDLs, or
the core of the DNA ligase. Several residues in the NTase have
been found to be fundamental for the enzyme activity, with modi-
fications bringing a considerable rate decrease or inactivation of
the enzyme. The essential amino acids in the NTase, their inter-
actions and their biochemical roles are summarized in Table 1
for the NDLs from E. coli [59,60] and M. tuberculosis [54,61].
The high conservation of NDLs is highlighted by the presence of
similar residues in NDLs from the two organisms, with the only
difference being that the stacking interaction to adenine occurs
with Tyr-225 in EcligA, while it is with His-236 in MtLigA.
Domain 2 contacts the double-stranded DNA, covers the nick
and helps in positioning it into the NTase domain. Its action is
supported by subdomain 3b, also referred to as HhH, which binds
both DNA strands in a non-specific sequence manner across the
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minor groove. The OB-fold, NTase and HhH have been shown to
clamp the double-strand DNA across 19 bp [55].
Subdomain 3a, the Cys4-type zinc finger, holds the OB-fold
and HhH at the appropriate structural positions during DNA bind-
ing [51,55,62]. Finally, the C-terminal domain 4, BRCT, has a
role for the DNA ligases that is still not fully explained. Indeed,
from the crystal structures of different enzymes, the BRCT do-
main appears as a flexible unit, with a structure that cannot to
be properly resolved, and it is apparently not essential for the
adenylation step [51,55,63]. Indeed, NDL proteins not including
BRCT in their modular structures are still able to perform their
ligation reaction, albeit at a lower rate [62–64]. However, DNA
binding was shown to be tighter for an enzyme with a BRCT
domain compared with one not containing it [64]. Therefore, the
BRCT domain could stabilize the DNA binding on NDLs, even
though it does not interact directly with DNA. Another possible
function for the BRCT domain could be as a signal transducer of
the DNA-damage response; indeed, other well-characterized pro-
teins use this domain for protein-protein interactions to transmit
signalling responses [51].
Overall, the modular structure of NDL allows it to catalyse
the ligation reaction by coordinating considerable movements
of the different domains. It is now clear that similar large-scale
conformation movements of the enzymes take place for ligation
reactions performed by the majority of NDLs and ADLs.
ASSAYS OF DNA JOINING BY DNA
LIGASES
The reaction catalysed by DNA ligases leads to changes in the
ends or backbone structure of DNA and such changes can be
detected using a range of biochemical and biophysical assays
[65]. Here we briefly review assays that are particularly useful
in analysing the influence of small molecules on the activity of
DNA ligases.
Gel electrophoresis is a convenient method for detecting the
sizes of molecules, and it has been widely used among the
primary biochemical studies of DNA ligases that are reviewed
here (e.g. see [64,66,67]). However, gel electrophoresis is rather
time-consuming and laborious and, thus, is not ideal for drug dis-
covery purposes. Therefore, to facilitate biochemical analyses of
DNA ligases and development of inhibitors against them, atten-
tion has focused on development of alternative assays to monitor
DNA joining activities. Some of these alternatives have been
specifically developed to offer increased throughput of assays
[68–70], different time resolution or are more cost-effective. In
some cases the developments take advantage of novel forms of
relevant molecules, such as a fluorescent derivative of β-NAD+
that can be processed by different β-NAD+ -consuming enzymes,
including NDLs [71].
A wide range of biophysical chemistry approaches have been
used to detect the joining of DNA strand breaks. Those ap-
plied to NDLs or ADLs from bacteria or archaea include use of
fluorescently-labelled probes [66,70,72,73], FRET [69,74–77],
fluorescence quenching and molecular beacon-based approaches
[78–81], electrochemical methods [67,79,81–84], a nanoparticle-
based sensor [85] and surface plasmon resonance [86]. Biochem-
ical analyses of the ligation reaction are facilitated by assays that
do not require ‘labelling’ of the nucleic acid, such as label-free
electrochemical approaches using mercury-based electrodes and
nicked plasmid DNA substrates [67]. Combinations of techniques
can also be powerful, as observed with the electrochemistry al-
ternative that uses a digoxigenin-labelled probe and detects liga-
tion via a ‘double-surface’ enzyme-linked electrochemical assay
[84]. Such techniques are fast and inherently versatile due to their
easy incorporation of synthetic oligonucleotide substrates, allow-
ing the DNA breaks to be situated in diverse sequence contexts
and/or structure perturbations.
As highlighted in many of these assays, oligonucleotide tem-
plates that are able to form stem-loop structures are popular since
they can be immobilized on different surfaces through biotin–
streptavidin interactions or direct linkage to gold surfaces. If the
other end of the stem-loop contains a label, then the absence or
presence of the label can be used to detect alteration to the back-
bone structure of DNA. By inclusion of a nick in DNA stem-loop
structures, then retention of the signal indicates DNA ligation
and such approaches have been monitored using fluorescence
[66,78,79] or electrochemical [81,82] techniques. Interestingly,
use of appropriate substrates in these assays allows study of the
combined action of nucleases and ligases [66], which allows ex-
tension of these assays to assess links between DNA ligases and
other proteins involved in nucleic acid metabolism, as observed
in DNA repair processes.
INHIBITORS AND NON-NATURAL
SUBSTRATES OF DNA LIGASES
Detailed characterization of DNA ligases at a biochemical and
molecular level has generated therapeutic interest, with the
essential NDLs of bacteria being a suggested target for novel
antibiotics candidates [2,7,8,11,12]. The starting point for many
studies that aim to inhibit such enzymes is to assess the effects
of modified derivatives of the co-factors, either β-NAD+ or
ATP in the case of DNA ligases. In assessing such compounds,
it is important to recognize that they may result in non-natural
substrate activity and, thus, may not inhibit the activity of the
enzyme [71,87]. Therefore, it is often necessary to test the
effects of many different types of modifications to the co-factors.
In the case of DNA ligases, modified co-factors have produced
a range of effects and it is not straightforward to predict their
effects, as we discuss below. Furthermore, an influence on the
enzyme activity does not necessarily require major alterations to
the chemical groups of the co-factor, as demonstrated recently
for T4 DNA ligase exhibiting stereo-selective properties towards
modified ATP compounds [88].
The first DNA ligase inhibitors that looked promising for
drug discovery purposes were discovered by screening librar-
ies of classes of compounds, such as alkaloids, flavonoids,
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pyridochromanones, quinoline and quinacrine derivatives [8,89–
91]. These compounds were then refined to generate analogues
that had improved activity, selectivity, solubility and other factors
that make the compounds more ‘druggable’ [53,74–76,92–98].
Importantly, some of these studies also highlighted the challenges
associated with developing such compounds as antimicrobial
drugs [96].
As described above, a variety of high-resolution structures of
NDLs have been resolved in the last decade, providing a better
understanding of the β-NAD+ binding site [7,55]. The substan-
tial conformational changes of the enzymes that occur during
the reaction – and the conformational flexibility of the enzymes
in general – makes rational design of inhibitors challenging. By
their very nature, structures from crystallographic studies capture
only a particular snapshot of the enzyme, which may or may not
be relevant for inhibitor binding. Several studies have undertaken
basic modelling of the structures of NDLs and virtual screening of
molecules that they interact with [8,53,55,61,63,87,91,98–100].
However, it is clear that detailed molecular dynamics studies of
NDLs would assist with structure-based design of inhibitors. In-
formation derived from the combination of different structures
has highlighted some useful approaches, particularly in relation
to the challenges and potential advantages of targeting the co-
factor binding site [3–5,7,15]. In particular, identification of the
existence of a hydrophobic tunnel (Figure 3) in proximity to N-1,
C-2 and N-3 of the adenine ring [7] has opened the opportunity
for the development of inhibitors that can fit into this tunnel (Fig-
ure 4). Moreover, the tunnel is not present in ADLs, therefore
potentially allowing for the generation of inhibitors that are more
specific towards NDLs.
Building on previous studies [52], crystallographic structures
were obtained for known inhibitors in complex with E. faecalis
LigA (PDB accession numbers 3BA8, 3BA9, 3BAA, 3BAB;
Pinko, Borchardt, Nikulin, Su, unpublished data). These struc-
tures showed the inhibitors fitting into the hydrophobic tunnel.
Intuitively, adenosine-based compounds substituted on C-2 of
the adenine ring fit perfectly into the active site positioning the
substituent into the tunnel; consequently, they have become a
prominent class of inhibitors (Table 2), extensively studied and
optimized to meet optimal drug criteria [92,95]. The scaffold
similarity to β-NAD+ and the lack of interference of substrate
activity make adenosine derivatives very promising inhibitors,
with IC50 in the low micromolar range.
Other potential inhibitors that have been assessed include
6-azaindazoles, 2-amino-[1,8]-naphthyridine-3-carboxamides
(ANCs) and aminoalkoxypyrimidine carboxamide (AAPCs)
(Figure 4). These compounds were modelled and synthesized to
resemble the orientation of adenine, ribose and C-2 substituents
into the active site with comparable inhibitory activity. Phos-
phorylated derivatives of adenosine, such as AMP, cAMP, ADP
and ATP substituted on C-2 of the adenine ring have also been
tested as inhibitors against NDLs with some promising results
(Table 3).
Despite this progress, there have been relatively few reports
of β-NAD+ derivatives as inhibitors of NDLs (Table 3). The
reasons for this include the difficult synthesis of β-NAD+ de-
Figure 3 NAD+ -dependent DNA ligases from bacteria contain a
conserved hydrophobic tunnel
All NAD+ -dependent DNA ligases from bacteria contain a hydrophobic
tunnel (shaded in orange). The structure is of E. coli LigA bound to ad-
enylated DNA from PDB 2OWO [55] and is visualized by UCSF Chimera.
The image in (A) shows the full structure, with image (B) zooming in to
give a clearer view of the location of the co-factor in the hydrophobic
tunnel. Note that the C-2 of the adenine ring of β -NAD+ points in the
direction of the hydrophobic tunnel.
rivatives, their relatively limited and modest stability, and their
flexible/multifunctional structure, which makes β-NAD+ bind-
ing quite unspecific. Such modified derivatives of β-NAD+ may
also result in non-natural substrate activity, though this prop-
erty can be exploited to provide useful insight into the catalytic
mechanisms of the enzymes [71,87].
Recent studies have assessed the biological activity of the β-
NAD+ derivatives and some of their corresponding AMP and
AMP-morpholidate derivatives. For example, using EcLigA and
MtLigA, the enzymes from E. coli and M. tuberculosis that are
among the best characterized NDLs, compounds modified in po-
sition 2, 6 or 8 of the adenine ring were tested as inhibitors
and/or non-natural substrates [87]. The different substitution pat-
terns on derivatives of β-NAD+ and AMP had a pronounced
effect on the biochemical activity of EcLigA and MtLigA. The
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Figure 4 Classes of NAD+ -dependent DNA ligase inhibitors and their position characteristics compared with the natural
substrate
The blue box identifies the part of the molecule that binds in the position of the adenine nucleobase; the purple box
identifies the part of the molecule that sits within the hydrophobic tunnel of NAD+ -dependent DNA ligases; the yellow box
identifies the sugar moiety binding site.
6-substituted derivatives were neither co-substrates (in the case
of the β-NAD+ derivatives) nor inhibitors (in the case of both
β-NAD+ and AMP derivatives) [87]. These results suggest that
the presence of an additional substituent in position 6 is not
tolerated by either EcLigA or MtLigA, and is detrimental for
co-substrate binding. None of the 8-substituted β-NAD+ deriv-
atives were utilized as co-substrates by EcLigA either, but two
were weak inhibitors [87]. This pattern of behaviour suggests
that 8-substituted β-NAD+ derivatives can bind at the active
site of NDLs, but do so in a non-productive orientation. Due
to the proximity of the protein backbone and position 8 of the
adenine ring, there is not enough space within the active site to
accommodate an additional substituent at this position without
changing the original position of the adenine. Thus, the binding of
8-substituted β-NAD+ derivatives at the active site probably oc-
curs in a different orientation from that of natural β-NAD+ and,
consequently, precludes establishment of key interactions within
the active site and, therefore, their co-substrate activity [87]. By
contrast, co-substrate and/or inhibitory activities were observed
in the series of 2-substituted derivatives highlighting that an addi-
tional substituent at the 2-position of β-NAD+ /AMP can be ac-
commodated by NDLs and may be involved in direct interactions
with the target DNA ligase [87]. This hypothesis is supported by
results from molecular docking experiments taking advantage of
the structure of EcLigA (PDB: 2OWO [55]), which suggest that
2-substituted AMP/β-NAD+ derivatives can be accommodated
at the active site in an orientation that is nearly identical with
that of natural AMP/β-NAD+ [87]. In this position, the adenine
ring of the compounds maintains all key interactions with active
site residues, whereas the substituent in position 2 fits into the
hydrophobic tunnel adjacent to the adenine binding site (Figure
3). However, different substituents may interact differently with
the residues in the tunnel; thus, although the 2-iodo substituent
may electrostatically interact with Lys-290 at the entrance of the
hydrophobic tunnel, a phenyl substituent does not appear to make
any specific contacts with residues in the tunnel, explaining the
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8 c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
Licence 4.0 (CC BY).
Biochemical characterization of DNA ligases
Table 2 IC50 values for nucleoside-based inhibitors of NAD+ -dependent DNA ligases from bacteria
Spn: Streptococcus pneumoniae; Sau: Staphylococcus aureus; Hin: Haemophilus influenza; Ec: Escherichia coli; Mpn: Mycoplasma pneumoniae. n.d.:
not determined. a Details from [75]; b details from [53]; c details from [76]; d details from [74]; e details from [94].
IC50 Spn IC50 Sau IC50 Hin IC50 Spn IC50 Ec IC50 Mpn
cmpd X Y Z R [μM] [μM] [μM] L75F [μM] [μM] [μM]
1a,c,d S OH OH n-Butyl 0.14 0.08 0.51 10 1.27 0.07
2a S H OH n-Butyl 0.13 0.17 n.d. n.d. n.d. n.d.
3a S OH OH c-Pentyl 0.44 0.38 n.d. n.d. n.d. n.d.
4a,b,c O OH OH c-Pentyl 0.15–0.21 0.43 0.51 30–33 n.d. n.d.
5a O F OH c-Pentyl 0.12 0.12 n.d. n.d. n.d. n.d.
6a,d O H OH c-Pentyl 0.08 0.12 0.11 n.d. 0.37 0.02
7a O H Cl c-Pentyl 0.04 0.04 n.d. n.d. n.d. n.d.
8a O F N3 c-Pentyl 0.07 0.09 n.d. n.d. n.d. n.d.
9a O OH Cl c-Pentyl 0.08 0.11 n.d. n.d. n.d. n.d.
10a O H dichlorobenzyl c-Pentyl <0.01 0.13 n.d. n.d. n.d. n.d.
11a,d O F OH Cyclobutyl methyl 0.05 0.06 0.08 n.d. 0.16 0.02
12a,c,d O H OH (trans-4-Methylcyclohexyl) 0.05 0.16 0.11 12 0.32 <0.01
13a,d O H OH Spiro[2.2]pent-1-ylmethyl 0.04 0.06 0.08 n.d. 0.18 0.06
14a O H Cl Spiro[2.2]pent-1-ylmethyl 0.02 0.03 n.d. n.d. n.d. n.d.
15a O H OH Bicyclo[3.1.0]hex-3-yl 0.06 0.13 n.d. n.d. n.d. n.d.
16a O F OH (1-Hydroxymethyl)
cyclopropyl methyl
0.40 0.37 n.d. n.d. n.d. n.d.
17a O H OH Phenyl 2.67 0.14 n.d. n.d. n.d. n.d.
18a O F OH 1,3-Thiazol-2-ylmethyl 0.87 0.91 n.d. n.d. n.d. n.d.
19e O H OH Decalin 0.04 n.d. 0.26 n.d. n.d. n.d.
20e O OH OH Decalin 0.08 n.d. 0.40 n.d. n.d. n.d.
21e O H OH Adamantane methyl 0.20 n.d. 1.7 n.d. n.d. n.d.
superior inhibitory activity of 2-iodo derivatives against 2-phenyl
derivatives toward EcLigA (Table 3).
Moreover, the availability of the two pairs of AMP/β-NAD+
derivatives with the same 2-substituent (2-iodo or 2-phenyl) en-
ables a detailed assessment of the role of the NMN fragment
for DNA ligase inhibition by base-modified adenine nucleotides.
The presence of the complete β-NAD+ scaffold, although not
an absolute prerequisite for inhibitory activity, altered the pro-
file of inhibition, leading to synergistic effects with β-NAD+
or overcoming the time-dependence of inhibition. Interestingly,
this inhibitory profile was again dependent on the nature of the
2-substituent suggesting that it has an important role for orient-
ing the NAD+ scaffold in the active site, and consequently for
subdomain closure [87]. In addition, a different general trend for
inhibition in the NAD+ derivatives against EcLigA and MtLigA
highlight that subtle differences in the shape of the hydrophobic
tunnel between EcLigA and MtLigA critically influence the bind-
ing of different 2-substituents and, consequently, the orientation
of 2-substituted β-NAD+ derivatives in the active site of the
respective DNA ligase. The results described for 2-substituted
derivatives of β-NAD+ [87] suggest that their effects are in-
fluenced by the large conformational changes required for full
activity of NDLs, highlighting the involvement of two distinct
nucleotide binding sites (see Figure 5, below). Additional, de-
tailed studies are required to identify which particular steps in
the reaction mechanism are inhibited by the variously modified
derivatives of β-NAD+ and to assess whether any of them have
any effects on bacteria.
Recently, the potential usefulness of adenosine-based inhibit-
ors carrying a substituent on C-2 of the adenine ring has been
questioned with the discovery of a ligase mutant, L75F, which
restricts the tunnel with >10-fold loss in antibacterial activity
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Table 3 IC50 values for nucleotide/dinucleotide-based inhibitors of NAD+ -dependent DNA ligases from bacteria
cAMPS: cyclic adenosine monophosphothioate; Ec: Escherichia coli; Mt: Mycobacterium tuberculosis. n.d.: not determined. a Details from [87];
b details from [68].
cmpd R R1 R2 R3 Scaffold IC50 Ec [μM] IC50 Mt [μM]
22a OH OH OH Lodo AMP 120 +− 23 16 +− 8
23a NMN OH OH Lodo NAD 138 +− 18 >200
24a NMN OH OH Phenyl NAD n.d. 73 +− 15
25b P2O7H3 OH OH S-Methyl ATP 1.1 n.d.
26b PO4H2 OH OH S-Methyl ADP 4.1 n.d.
27b S R1 = R2 O S-Methyl cAMPS 1.5 (S)120 (R) n.d.
and >100-fold loss in target binding [74,76]. A more recent class
of inhibitors based on a thienopyridine scaffold (Figure 4) avoids
the presence of substituents fitting into the tunnel and resembles
only the orientation of adenine and ribose within the binding site.
MECHANISM OF DNA LIGATION BY
NAD + -DEPENDENT DNA LIGASES
Biochemical studies of DNA ligases began with discovery of
the enzymes in the 1960s. The most intensively studied NDL
is EcLigA from E. coli, which is unsurprising since it was the
first bacterial DNA ligase to be characterized biochemically [1–
3,13]. Studies of EcLigA continue to give useful insights into the
reaction mechanism of NDLs, as observed with a recent kinetic
analysis that examined the way in which base-pairing at the nick
in the DNA influences the activity of the enzyme [101].
As already highlighted, NDLs follow a ping-pong mechanism
(Figure 5), with β-NAD+ leading to an adenylated intermediate
(E-AMP) at a conserved nucleophilic lysine residue (Lys-115 in
EcLigA). Throughout these reaction steps, both the DNA ligase
and the bound β-NAD+ co-factor undergo significant conforma-
tional changes. The two subdomains 1a and 1b of the N-terminal
adenylation domain of DNA ligases include binding sites for, re-
spectively, the NMN (subdomain 1a) and AMP (subdomain 1b)
moieties of β-NAD+ . The binding of the β-NAD+ co-factor
triggers the closure of subdomain 1a on to subdomain 1b, and the
transition from an ‘open’ to a ‘closed’ conformation (Figure 5),
which is critical for DNA ligase activity [52,57]. Note that pro-
gress from one ‘open’ intermediate to the next can only occur by
passing through a ‘closed’ intermediate, meaning that multiple,
large-scale changes take place during the overall reaction. Stud-
ies with H. influenzae LigA suggest that the initial recognition
of β-NAD+ occurs at the NMN binding site on subdomain 1a,
providing an explanation for the selectivity of bacterial DNA lig-
ases for β-NAD+ over ATP [57]. In the closed conformation, the
adenine of β-NAD+ is bound tightly to the active site by several
key interactions with conserved residues, such as Lys-290 (H-
bonding to N1), Glu-113 (H-bonding to N6) and Tyr-225 (π–π
stacking) in EcLigA; in particular, the interaction with Lys-290 is
critical for enzymatic activity [55]. Taken together, these interac-
tions hold the adenine ring in place, although the conformation of
the AMP moiety changes, through rotation of the ribose about the
N-glycosidic bond, from syn in non-covalently bound β-NAD+ ,
to anti in the adenylate-ligase intermediate, and back to syn in
the adenylated-DNA intermediate [55].
CONCLUSIONS
DNA ligases are essential enzymes for all cells because they seal
breaks in DNA backbones and, thus, ensure that its structural
integrity is maintained. Recognition that the essential DNA lig-
ases in bacteria use a different co-factor (β-NAD+ ) compared
with the ATP co-factor that is used by the eukaryotic enzymes
raised hopes that they could be targeted by novel antibiotics. Un-
til recently, progress in this aim has been hampered due to the
difficult synthesis of β-NAD+ derivatives and their relatively
limited stability. However, the complex molecular structure of
β-NAD+ affords multiple opportunities for chemical modifica-
tion and several recent studies have synthesized promising novel
derivatives.
The biological activity of these compounds have been eval-
uated as inhibitors for drug discovery and such modified
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Figure 5 Reaction mechanism for DNA ligation by NAD+ -dependent DNA ligases
The enzyme uses a ping-pong mechanism, with β -NAD+ leading to an adenylated intermediate (Lig-AMP) at a conserved
nucleophilic lysine residue. The N-terminal adenylation domain of DNA ligases include binding sites for the NMN (subdomain
1a) and AMP (subdomain 1b) moieties of β -NAD+. The binding of the β -NAD+ co-factor triggers the closure of subdomain
1a on to subdomain 1b, and the transition from an ‘open’ to a ‘closed’ conformation, which is critical for DNA ligase
activity. In the closed conformation, the adenine of β -NAD+ is bound tightly to the active site by several key interactions
with conserved residues. These interactions hold the adenine ring in place although the conformation of the AMP moiety
changes from syn in non-covalently bound β -NAD+ to anti in the adenylate-ligase intermediate, and back to syn in the
adenylated-DNA intermediate. Progress from one ‘open’ intermediate to the next can only occur by passing through a
‘closed’ intermediate, meaning that multiple, large-scale changes take place during the overall reaction; see text for
further details. Similar large-scale conformational changes occur during ligation by ATP-dependent DNA ligases, but the
specific details vary for each version of those enzymes.
derivatives of β-NAD+ also result in non-natural substrate activ-
ity that can be exploited to provide useful insight into the cata-
lytic mechanisms of DNA ligases. Summarizing recent results, it
is clear that aryl/heteroaryl substitutions on different positions of
the adenine ring generate β-NAD+ derivatives with biological
activities toward β-NAD+ -consuming enzymes. The preferen-
tial action of aryl/heteroaryl adenine-modified β-NAD+ deriv-
atives as inhibitors and/or non-natural substrates toward specific
β-NAD+ -consuming enzymes offers the prospect of their use
for in vitro/in vivo studies. Such a step forward in their biolo-
gical evaluation will require consideration of their activity and
stability within cells, such as their ability to resist degradation by
ecto β-NAD+ -consuming enzymes or intracellular nucleases.
Therefore, chemical modifications on the β-NAD+ scaffold or
alternative methods of delivery will need to be developed with
a focus on the use for which they are designed. However, the
validity of the use of such compounds as biochemical probes is
already a useful place to widen the knowledge of fundamental
biological processes involving β-NAD+ -consuming enzymes.
Biochemical and structural studies have made significant pro-
gress in identifying compounds that inhibit NDLs. However, the
prospects of developing such compounds as antimicrobial drugs
remains challenging, particularly since it is likely that effect-
ive drugs will have to inhibit NDLs very efficiently, with very
good discrimination against ADLs [21,96]. Recent comparative
analysis of co-factor and inhibition experiments raises the pos-
sibility that useful inhibition may be obtained due to targeting
of the significant conformational changes that occur within DNA
ligases during their catalytic cycle. Importantly, such findings
may provide a promising starting point for the rational design of
new classes of inhibitors against bacterial DNA ligases. It is also
notable that most studies of potential inhibitors have assessed
the effects of compounds that bind reversibly to DNA ligases.
Compounds that bind to NDLs through covalent binding could
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offer novel solutions to the need to inhibit the enzymes very
efficiently in the cell. Detailed molecular dynamics studies are
likely to offer valuable insights into useful avenues to explore in
the development of improved inhibitors of NDLs.
In summary, although progress to identify useful compounds
that target DNA ligases has been rather frustrating, the recent
development of modified derivatives of nucleotides offers en-
couragement for such studies. The continued combination of
structural, biochemical and biophysical techniques will be useful
in targeting these essential cellular enzymes.
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